Correlation Between MAIA Biotechnology and Clarity Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and Clarity Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and Clarity Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and Clarity Pharmaceuticals, you can compare the effects of market volatilities on MAIA Biotechnology and Clarity Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of Clarity Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and Clarity Pharmaceuticals.
Diversification Opportunities for MAIA Biotechnology and Clarity Pharmaceuticals
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between MAIA and Clarity is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and Clarity Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clarity Pharmaceuticals and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with Clarity Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clarity Pharmaceuticals has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and Clarity Pharmaceuticals go up and down completely randomly.
Pair Corralation between MAIA Biotechnology and Clarity Pharmaceuticals
Given the investment horizon of 90 days MAIA Biotechnology is expected to generate 0.73 times more return on investment than Clarity Pharmaceuticals. However, MAIA Biotechnology is 1.38 times less risky than Clarity Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Clarity Pharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest 209.00 in MAIA Biotechnology on October 26, 2024 and sell it today you would lose (16.00) from holding MAIA Biotechnology or give up 7.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 97.5% |
| Values | Daily Returns |
MAIA Biotechnology vs. Clarity Pharmaceuticals
Performance |
| Timeline |
| MAIA Biotechnology |
| Clarity Pharmaceuticals |
MAIA Biotechnology and Clarity Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MAIA Biotechnology and Clarity Pharmaceuticals
The main advantage of trading using opposite MAIA Biotechnology and Clarity Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, Clarity Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clarity Pharmaceuticals will offset losses from the drop in Clarity Pharmaceuticals' long position.| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
| Clarity Pharmaceuticals vs. Pool Corporation | Clarity Pharmaceuticals vs. SunOpta | Clarity Pharmaceuticals vs. Suburban Propane Partners | Clarity Pharmaceuticals vs. MYT Netherlands Parent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |